The Foundation for the NIH has announced the launch of a public-private partnership to advance knowledge of and accelerate drug development for individuals affected by amyotrophic lateral sclerosis.the Accelerating Medicines Partnership in Amyotrophic Lateral Sclerosis (AMP ALS), launched with roughly $60 million in funding, will combine resources and expertise of the National Institute of